Petrelintide Delivers Significant Weight Loss in Diabetes Trial
Zealand Pharma reported results from a Phase 2 clinical trial for its amylin-based drug, petrelintide. The study focused on adults suffering from both obesity and type 2 diabetes. Over a period of…